# A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated

> **NCT03550378** · PHASE2 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 41 (actual)

## Conditions studied

- Type II Diabetes Mellitus
- Renal Insufficiency

## Interventions

- **DRUG:** MEDI0382
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03550378
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-29
- **Primary completion:** 2019-02-04
- **Final completion:** 2019-02-04
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2020-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03550378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03550378, "A Study to Look at the Effect MEDI0382 Has on Blood Sugar in People With Type 2 Diabetes and Kidney Problems and Also to Check That MEDI0382 is Well Tolerated". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT03550378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*